Robert Debernardo

University Hospitals Cleveland Medical Center, Cleveland Clinic

Papers

Total Citations

H-Index

About

Robert Debernardo is a clinician-researcher whose work sits at the intersection of gynecologic oncology and advanced surgical and radiotherapeutic techniques. His research has focused primarily on improving outcomes for women with gynecologic cancers through the adoption of cutting-edge, minimally invasive approaches. In his 2011 contribution to the field of robotic surgery, Debernardo helped establish the clinical rationale for surgeon-manipulated robotic instrumentation in the removal of cancer-bearing gynecologic tissues, recognizing early that minimally invasive techniques could match or surpass traditional open surgery in oncologic outcomes — a paper that has since garnered 8 citations. His 2014 investigation into acute gastrointestinal toxicity following stereotactic ablative radiotherapy (SABR) addressed a critical safety question for women with recurrent gynecological malignancies in the upper abdomen, studying 34 patients to better characterize the risks of high-precision radiation therapy — accumulating 5 citations. Together, these contributions reflect Debernardo's commitment to refining both surgical and radiation-based cancer treatment strategies, helping to shape evidence-based practices that prioritize patient safety and quality of life in the management of complex gynecologic malignancies.